Santosh, P. http://orcid.org/0000-0003-4830-5893
Cortese, S.
Hollis, C.
Bölte, S.
Daley, D.
Coghill, D.
Holtmann, M.
Sonuga-Barke, E. J. S.
Buitelaar, J.
Banaschewski, T.
Stringaris, A.
Döpfner, M.
Van der Oord, S.
Carucci, S.
Brandeis, D.
Nagy, P.
Ferrin, M.
Baeyens, D.
van den Hoofdakker, B. J.
Purper-Ouakil, D.
Ramos-Quiroga, A.
Romanos, M.
Soutullo, C. A.
Thapar, A.
Wong, I. C. K.
Zuddas, A.
Galera, C.
Simonoff, E.
Article History
Received: 14 June 2022
Accepted: 19 January 2023
First Online: 11 February 2023
Declarations
:
: Jan K Buitelaar has been in the past 3 years a consultant to/member of the advisory board of/and/or speaker for Takeda/Shire, Roche, Medice, Angelini, Janssen, and Servier. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, royalties. Paramala Santosh is the CEO and shareholder of HealthTracker Ltd. He has also received research funds and honoraria from Anavex Scientific Corporation, Newron Pharma, and GW Pharma, and research funds from Reverse Rett, a charity. Samuele Cortese declares honoraria and reimbursement for travel and accommodation expenses for lectures from the following non-profit associations: Association for Child and Adolescent Central Health (ACAMH), Canadian ADHD Alliance Resource (CADDRA), British Association of Pharmacology (BAP), and from Healthcare Convention for educational activity on ADHD. Professor Daley has provided educational talks for Medice and Shire/Takeda, attended advisory boards for Shire/Takeda. Received support for educational travel from Shire/Takeda, QbTech and Medice. He has also received royalties from the sale of a self-help version of the New Forest Parenting Programme and research funding from NIHR, ESRC and Shire/Takeda. David Coghill served in an advisory or consultancy role for Medice, Novartis, and Takeda. He received conference support or speaker’s fee from Medice, Servier, and Takeda. He received royalties from Cambridge University Press and Oxford University Press; the present work is unrelated to these relationships. Martin Holtmann served in an advisory role for Shire, Takeda and Medice and received conference attendance support or was paid for public speaking by Medice, Shire and Neuroconn. He received research support from the German Research Foundation and the German Ministry of Education and Research. He received royalties as Editor-in-Chief of the German Journal for Child and Adolescent Psychiatry and for textbooks from Hogrefe. Diane Purper Ouakil reports in the past 3 years honoraria and non-financial support from Medice and Shire/Takeda, and non-financial support from HAC Pharma, outside the submitted work. Edmund Sonuga-Barke has received speaker fees from Takeda/Shire and Medice, consultancy from Neurotech Solutions and grant support from QBTech. Tobias Banaschewski served in an advisory or consultancy role for ADHS digital, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or speaker’s fee by Janssen, Medice and Takeda. He received royalties from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press; the present work is unrelated to these relationships. Cesar A. Soutullo is a Full Time Employee of The University of Texas Health-Houston. In the past three years, he has served in advisory board/consultancy roles for Editorial Medica Panamericana, Innosphere (Germany), Limbix (USA), MEDEA (Spain), Medice (Germany), and NeuroTech Solutions Ltd (Israel). He served on the Speaker’s Bureau/CME Talks for Bial (Portugal), Cuquerella Medical Consulting (Spain), Medice (Germany), Rubio (Spain), Tecnofarma (Peru). Has received royalties from Editorial Médica Panamericana and Mayo Ediciones, Springer. His research is supported in part by the Texas Child Mental Health Care Consortium. Anita Thapar’s textbook royalties are paid to Cardiff University. Maite Ferrin has received honoraria from Medice for one congress in 2019 and has contributed to Novartis advisory board in 2019. Peter Nagy has received consultancy fees from Lilly and Medice and conference support from Egis Pharmaceuticals. Saskia van der Oord has no conflicts of interest. Sara Carucci had collaborations with projects from the European Union (7th Framework Program) and in sponsored clinical trials by Lundbeck, Otsuka, Janssen-Cilag, Acadia and Angelini. Chris Hollis was a member of the NICE ADHD Guideline [NG87] Committee. He has conducted research on QbTest funded by the National Institute of Health Research (NIHR). Sven Bölte discloses has in the last 3 years acted as an author, consultant or lecturer for Medice and Roche. He receives royalties for textbooks and diagnostic tools from Hogrefe, and Liber. Bölte is shareholder in SB Education/Psychological Consulting AB and NeuroSupportSolutions International AB. Barbara van den Hoofdakker receives royalties from Van Gorcum. Alessandro Zuddas served in an advisory or consultancy role for Angelini, Janssen, Servier, Takeda, INCIPIT, and grant support from Lundbeck, Janssen, Otsuka, Servier, and the European Union (Innovative Medicine Initiative 2), He also received royalities from Giunti Psychometrics, Hoegrefe and Oxford University Press.